Based on our recent identification that APC and K-Ras mutations synergistically enhance liver metastasis of CRC cells via stabilization of both β-catenin and Ras [9], small molecules destabilizing both β-catenin and Ras could be an effective therapeutic strategy to prevent metastasis to secondary organ. This evidence concerns the gene KRAS and colorectal carcinoma.